MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-150

  1. 11,104 Posts.
    lightbulb Created with Sketch. 696
    I have been thinking about the need for 2 independent parties being involved in trial design BEFORE the FDA gets a look see and say.

    Lawyers involved already?

    This being a legal defence against bias or worse claims?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.